Back to company

Symbiotiq Invest Holding ApS: Financial statements 2024

CVR: 43719335

Symbiotiq Invest Holding ApS (CVR 43719335) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,030 and a net result of DKK -785 compared with DKK -6,857 the year before. Equity amounted to DKK 32,358. The solvency ratio was 88.2%.

Gross Profit
-1,030 kr.
Profit/Loss
-785 kr.
Equity
32,358 kr.
Total Assets
36,703 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--1 t.-78532 t.-
2023--4 t.-7 t.33 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Symbiotiq Invest Holding ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Symbiotiq Invest Holding ApS: The 2023 annual report is outFeb 6, 2024

Symbiotiq Invest Holding ApS has published its annual report for 2023. Gross profit came to DKK -4,250, and the net result was DKK -6,857.

About Symbiotiq Invest Holding ApS

Symbiotiq Invest Holding ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mads Bonde. The company is owned by Symbiotiq ApS. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -300 compared with DKK -785 the year before. Equity amounted to DKK 32,058.

Other financial years